Trial
NCT00690456
Effect of Rimonabant and Metformin Combination on Glycemic Control in Patients With Type 2 Diabetes
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Sanofi
Collaborators
—
Condition
Diabetes Mellitus, Type 2
Intervention
Rimonabant
Why stopped
Company decision taken in light of demands by certain national health authorities
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-05-18